Travoprost 75MCG
Active Awarded Last action
- Contract number
- 36C25226N0252
- Awardee
-
Avedro, Inc. UEI XVMEKBSUMGZ7 Part of Glaukos Corporation
- Awarding agency
-
Veterans Integrated Service Network 12
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $169,105
Award facts
- Contract value 100% obligated
- $169,104.64 Current and potential, with all options
- Completion date 74% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Waltham, MA 02451, USA
Award details come from SAM.gov/FPDS.
About this award
Avedro, Inc., a subsidiary of Glaukos Corporation specializing in ophthalmic medical devices and pharmaceuticals, was awarded a delivery order valued at $169,104.64 for Travoprost 75 micrograms by Veterans Integrated Service Network 12 (VISN 12), a civilian agency within the Department of Veterans Affairs. The contract, awarded February 1, 2026, with an ultimate completion date of January 31, 2027, operates under a firm fixed-price structure with no set-aside designation. The place of performance is located in Waltham, Massachusetts. This delivery order is issued against Avedro's broader Federal Supply Schedule contract under the Pharmaceuticals and Drugs (FSS-61-IB) schedule, which carries a ceiling value of $584,000.00 and enables streamlined acquisition of specialized ophthalmic pharmaceutical products across multiple VA regional networks.
The award reflects Avedro's established position as a pre-approved supplier within the VA healthcare procurement ecosystem, having consistently demonstrated capability to deliver specialized pharmaceutical implants and solutions to various Veterans Integrated Service Networks on a competitive, full and open basis. Travoprost is a prostaglandin analog ophthalmic medication commonly used in the treatment of glaucoma and ocular hypertension, aligning with Glaukos Corporation's core focus on innovative eye-related medical technologies. The delivery order structure provides VISN 12 with efficient access to this specialized medication through an existing indefinite delivery vehicle, facilitating responsive procurement for VA healthcare facilities serving veterans.
Quick answers
Who was awarded contract 36C25226N0252?
36C25226N0252 was awarded to Avedro, Inc. by Veterans Integrated Service Network 12 (Veterans Health Administration) on February 1, 2026.
How much is contract 36C25226N0252 worth?
The government has obligated $169,105 on 36C25226N0252.
Is contract 36C25226N0252 an order under another contract?
Yes. 36C25226N0252 is a delivery order under 36F79723D0126, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C25226N0252 competed?
The extent of competition for 36C25226N0252 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award